Recent Finacing
Recent Raise
Carmine Therapeutics develops REGENT, an RBCEV-based non‑viral gene delivery platform that transports DNA/RNA (20 bp–>30 kb), enables multi‑payload delivery and broad tissue biodistribution, advancing retinal, pulmonary, and rare‑disease programs.
